Seegnal (FRA:2I1) Other Stockholders Equity: €0.21 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2I1 Seegnal Inc FRA:2I1
2 GF Score
Price €0.14
! 3 Warning Signs
View Full Analysis

What is Seegnal Other Stockholders Equity?

Seegnal FRA:2I1 -0.42% 2 Other Stockholders Equity is €0.21 Mil as of Mar. 2026. GuruFocus rates FRA:2I1 with a GF Score™ of 2/100. The stock has 3 warning signs investors should review.

Seegnal's Other Stockholders Equity for the quarter that ended in Mar. 2026 was €0.21 Mil.

Seegnal's quarterly Other Stockholders Equity increased from Sep. 2025 (€0.16 Mil) to Dec. 2025 (€0.20 Mil) and increased from Dec. 2025 (€0.20 Mil) to Mar. 2026 (€0.21 Mil).

Seegnal's annual Other Stockholders Equity increased from . 20 (€0.00 Mil) to Dec. 2024 (€0.02 Mil) and increased from Dec. 2024 (€0.02 Mil) to Dec. 2025 (€0.20 Mil).

Seegnal Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Seegnal's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Seegnal Other Stockholders Equity Chart

Seegnal Annual Data
Trend Dec24 Dec25
Other Stockholders Equity
0.02 0.20

Seegnal Quarterly Data
Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial 0.00 0.02 0.16 0.20 0.21
FRA:2I1
2GF Score
Seegnal Inc FRA:2I1
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Seegnal Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €0.21 Mil mean?
Seegnal (FRA:2I1) has a Other Stockholders Equity of €0.21 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Seegnal and its competitors.
Is Seegnal's Other Stockholders Equity too high?
Seegnal's current Other Stockholders Equity is €0.21 Mil. Overall, Seegnal has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does Seegnal's Other Stockholders Equity compare to VEEV and BTSG?
Seegnal's Other Stockholders Equity of €0.21 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Seegnal and its competitors. Seegnal's current Other Stockholders Equity is €0.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seegnal stock overvalued right now?
Seegnal (FRA:2I1) has a current Other Stockholders Equity of €0.21 Mil. The current Other Stockholders Equity is €0.21 Mil. Seegnal's overall GF Score™ is 2/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Seegnal (FRA:2I1), the current Other Stockholders Equity is €0.21 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Seegnal Business Description

Other Exchanges SEGN:Canada
Address 400-5th Avenue. SW, 300 Roslyn Building, Calgary, AB, CAN, T2P 0L6
Seegnal Inc is a med-tech software as a service (SaaS) company focused on the development and commercialization of a patient-centric clinical decision support system designed to mitigate drug-related problems at the point of care. It provides AI-enhanced clinical decision support software that helps healthcare providers prescribe medications safely and efficiently at the point of care (the Seegnal Platform). It analyzes patient-specific clinical data and medication regimens in real time to identify potential drug-related risks, including drug-drug interactions, contraindications, and adverse drug events. By integrating with electronic medical record systems, its platform supports clinicians in improving patient safety, optimizing medication use, and reducing healthcare costs.
2GF Score

Get the complete analysis for FRA:2I1

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.14
Price